| NASDAQ (NMS) Exchange | US Country |
The fund is designed for investors looking for exposure to the biotechnology sector of the stock market. It operates by investing in financial instruments that its advisors believe will, in combination, help achieve daily returns consistent with the fund's Daily Target. The specific focus is on the biotechnology segment of the S&P Total Market Index, which encompasses a range of companies within the biotech sub-industry. This investment approach highlights the fund's commitment to targeting potentially high-growth opportunities within the biotechnology field. Notably, the fund is non-diversified, meaning it may invest a larger percentage of its assets in fewer stocks, potentially leading to higher volatility and risk, as well as the possibility of higher returns.
The primary service offered by the fund is its focus on achieving returns that align with a pre-set daily target. This is carried out through strategic investments in financial instruments related to the biotechnology sector. By aiming for daily target returns, the fund seeks to provide a unique investment opportunity for investors interested in the dynamic biotechnology market.
Through its investment strategy, the fund provides investors with exposure to the biotechnology segment of the S&P Total Market Index. This encompasses a variety of biotech companies, allowing investors to tap into the growth potential of this innovative and rapidly evolving sector. The focus on a single, high-growth industry segment is intended to offer investors the opportunity for significant returns, albeit with a higher risk profile compared to more diversified funds.